692 filings
Page 4 of 35
144
Pamela P Palmer
24 Aug 23
Notice of proposed sale of securities
4:23pm
10-Q
2023 Q2
TLPH
Talphera Inc.
Quarterly report
10 Aug 23
5:00pm
8-K
TLPH
Talphera Inc.
10 Aug 23
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:10pm
EFFECT
TLPH
Talphera Inc.
10 Aug 23
Notice of effectiveness
12:15am
424B7
TLPH
Talphera Inc.
9 Aug 23
Prospectus with selling stockholder info
5:29pm
UPLOAD
TLPH
Talphera Inc.
7 Aug 23
Letter from SEC
12:00am
CORRESP
TLPH
Talphera Inc.
7 Aug 23
Correspondence with SEC
12:00am
S-3
TLPH
Talphera Inc.
Shelf registration
2 Aug 23
6:06am
SC 13G
TLPH
Talphera Inc.
1 Aug 23
ACELRX PHARMACEUTICALS / Lind Global Fund II ownership change
12:00am
8-K
TLPH
Talphera Inc.
31 Jul 23
Other Events
9:47pm
D
TLPH
Talphera Inc.
28 Jul 23
$10.00 mm in equity / options / securities to be acquired, sold $10.00 mm, 10 investors
2:07pm
8-K
TLPH
Talphera Inc.
21 Jul 23
Entry into a Material Definitive Agreement
8:15am
8-K
TLPH
Talphera Inc.
15 Jun 23
Other Events
4:06pm
10-Q
2022 Q1
TLPH
Talphera Inc.
Quarterly report
10 May 23
5:01pm
8-K
TLPH
Talphera Inc.
10 May 23
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
10-K/A
2022 FY
TLPH
Talphera Inc.
Annual report (amended)
1 May 23
6:20am
8-K
TLPH
Talphera Inc.
28 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
UPLOAD
TLPH
Talphera Inc.
11 Apr 23
Letter from SEC
12:00am
CORRESP
TLPH
Talphera Inc.
11 Apr 23
Correspondence with SEC
12:00am
8-K
TLPH
Talphera Inc.
7 Apr 23
AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals
3:37pm